Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
This product is supplied strictly for laboratory research purposes and is intended solely for use by qualified researchers and professionals in controlled scientific settings
As the primary factors for the reduced anticancer effect 1) the reduced delivery and uptake of the anticancer agent, 2) the need for the conversion of molecular oxygen (O 2 ) into reactive oxygen species (ROS), 3) the preferred therapeutic effect against highly proliferating cells, which is reduced under hypoxic conditions, or 4) adaptation of the cancer cells by promoting cell survival and upregulating certain resistance pathways, has been suggested 1,2,3,4,5
*NotePlease download the relevant files within the validity period
Once treatments stop, results gradually fade
Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: role of nanoparticle-based drug delivery systems in clinical translation
US$ 26.86
US$ 27.42
US$ 27.05
US$ 29.06
US$ 28.50
US$ 26.52
US$ 27.02
US$ 26.76
US$ 20.33
